Medicine guide

Pulmicort 200 Turbuhaler

As listed in the register: Pulmicort 200 Turbuhaler, 200 microgram/dosis, inhalatiepoeder

200 microgram/dosis · inhalatiepoeder

  • Prescription only
  • Breathing, airways, allergies and cough
Active substance
Budesonide
Made by
AstraZeneca B.V

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupBreathing, airways, allergies and coughR03BA02

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

From the US prescribing label for the same active substance (Budesonide Inhalation Suspension). It describes the substance, not this exact product.

Budesonide is an anti-inflammatory corticosteroid that exhibits potent glucocorticoid activity and weak mineralocorticoid activity.

In standard in vitro and animal models, budesonide has approximately a 200-fold higher affinity for the glucocorticoid receptor and a 1000-fold higher topical anti-inflammatory potency than cortisol (rat croton oil ear edema assay).

Peak level after20 min
Half-life2.3 h
Mostly cleared after≈ 11.5 hfive half-lives — our arithmetic
PeakHalf gone11.5 h0
The shape is a standard model drawn from the two times above, not a measurement. How fast a medicine acts and wears off also depends on the dose, the form and the person.
How the body breaks it down

In vitro studies with human liver homogenates have shown that budesonide is rapidly and extensively metabolized.

How it leaves the body

Budesonide is excreted in urine and feces in the form of metabolites.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-06-10

Safety of the active substance

From the US prescribing label for the same active substance (Budesonide Inhalation Suspension). It describes the substance, not this exact product.

Serious warning

Only use budesonide inhalation suspension with a jet nebulizer machine that is connected to an air compressor.

Must not be used by
  • Primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required.
  • ( 4 ) Hypersensitivity to any of the ingredients in budesonide inhalation suspension ( 4 ) The use of budesonide inhalation suspension is contraindicated in the following conditions:.
  • Hypersensitivity to budesonide or any of the ingredients of budesonide inhalation suspension [see Warnings and Precautions ( 5.3 ), Description ( 11 ),Adverse Reactions( 6.2 ) ].
Most common side effects

Most common adverse reactions (incidence ≥3%) are respiratory infection, rhinitis, coughing, otitis media, viral infection, moniliasis, gastroenteritis, vomiting, diarrhea, abdominal pain, ear infection, epistaxis, conjunctivitis, rash ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Cipla Ltd 1-866-604-3268 or FDA at 1-800-FDA-1088 or FDA or www.fda.gov/medwatch.

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byAstraZeneca B.V
Active substanceBudesonide
Used inBreathing, airways, allergies and cough
Strength200 microgram/dosis
Forminhalatiepoeder
ClassificationR03BA02 · Breathing, airways, allergies and cough
Routeinhalatie
Dispensing (as stated by the register)Uitsluitend recept
Name in the registerPulmicort 200 Turbuhaler, 200 microgram/dosis, inhalatiepoeder
RVG13698

Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician

Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).

Other strengths and forms

4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.